期刊文献+

乳腺癌超声征象与分子亚型相关性的研究 被引量:17

Correlation of sonographic features with molecular subtypes in patients with breast cancer
原文传递
导出
摘要 目的:探讨乳腺癌超声征象与分子亚型的关系。方法:回顾分析自2009年3月至12月经病理检查证实的128例乳腺癌患者,均有有雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(HER2)免疫组织化学检测等资料及术前行超声检查的超声图像,以免疫组织化学技术为基础,将乳腺癌分为3个分子亚型,即三阴性型(ER、PR、HER2均阴性)、Luminal型(ER阳性或PR阳性,HER2阴性或阳性)和HER2过表达型(ER阴性、PR阴性、HER2阳性)。结果:3个亚型的乳腺癌其超声征象在肿块的形状、生长方位、边界、边缘、后方回声特征、是否存在微钙化方面差异均有统计学意义(P<0.05);三阴性型乳腺癌多边界清晰(85.3%),边缘规则(47.1%),后方不伴回声衰减(23.5%)及较少出现微钙化(32.4%);HER2过表达型相对于Luminal型及三阴性型更易出现微钙化(56.5%),差异有统计学意义(P<0.05);Luminal型相对其他亚型更易出现高回声晕(18.3%),差异亦有统计学意义(P<0.05)。结论:乳腺癌超声表现与其分子亚型间存在相关性。 Objective To study the correlation between ultrasonographic features and molecular subtypes of breast cancer.Methods Ultrasounographic findings of 128 patients with pathologically confirmed breast cancer from March to December 2009 were retrospectively analyzed.Patients were categorized into 3 molecular subtypes : triple-negative group [ER(-),PR(-) and HER2(-),n=34],Luminal group [ER(+) or PR(+),with HER2(-) or HER2(+),n=71],HER2 group [ER(-),PR(-) and HER2(+),n=23].Results Different molecular subtypes differed in tumor shape,tumor orientation,margin,boundary,posterior echo and microcalcification on ultrasonography(P0.05).Triple-negative breast cancers were more likely to have clear boundary(85.3%),circumscribed margin(47.1%) and were less associated with posterior acoustic shadowing(23.5%) and microcalcification(32.4%) on ultrasonography.Microcalcification was more frequently seen in HER2 group(56.5%)when compared with triple negative group and Luminal group.Luminal group was most likely to have echogenic halo(18.3%)(P0.05).Conclusions Correlation exists between ultrasonographic features and molecular subtypes of breast cancer.
出处 《诊断学理论与实践》 2011年第2期153-157,共5页 Journal of Diagnostics Concepts & Practice
关键词 乳腺癌 超声 分子免疫学分型 Breast neoplasms Ultrasonography Molecular immunology subtyping
  • 相关文献

参考文献17

  • 1倪新初,孙苏平.乳腺癌的分子亚型及治疗策略研究进展[J].癌症进展,2009,7(4):422-426. 被引量:4
  • 2连臻强,何洁华,王曦,唐军,杨名添.乳腺癌不同分子亚型的临床特点和生存分析[J].中华乳腺病杂志(电子版),2009,3(2):5-9. 被引量:45
  • 3Yang WT,Tse GM.Sonographic,mammographic,and histopathologic correlation of symptomatic ductal carcinoma in situ[J].AJR,2004,182(1):101-110.
  • 4Yang WT,Dryden M,Broglio K,et al.Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women[J].Breast Cancer Res Treat,2008,111(3):405-410.
  • 5Wang Y,Ikeda DM,Narasimhan B,et al.Estrogen receptor-negative invasive breast cancer:imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression[J].Radiology,2008,246 (2):367-375.
  • 6Kim SH,Seo BK,Lee J,et al.Correlation of ultrasound findings with histology,tumor grade,and biological markers in breast cancer[J].Acta Oncol,2008,47(8):1531-1538.
  • 7谭旭艳,吴丹,高志刚.乳腺浸润性导管癌超声声像与分子免疫学指标检测相关性探讨[J].中国肿瘤外科杂志,2010,2(3):142-145. 被引量:2
  • 8黄巍,程文,向佳兵,高崧瀛.乳腺癌声像图征象与分子生物学之间的相关性研究[J].中国超声医学杂志,2010,26(11):970-973. 被引量:25
  • 9American College of Radiology.Breast imaging reporting and data system (BI-RADS)-Ultrasound[M].Reston:American College of Radiology,2003.
  • 10Guerra I,Algorta J,Diaz de Otazu R,et al.Immunohistochemical prognostic index for breast cancer in young women[J].Mol Pathol,2003,56(6):323-327.

二级参考文献20

  • 1何敬海,秦玲,陈东风,刘阿庆,安霞,王少春,曹长军,韩友东.乳腺浸润性导管癌的超声诊断特征[J].济宁医学院学报,2006,29(4):23-24. 被引量:2
  • 2Harris L,Fritsche H,Mennel R,et al.American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer[J].J Clin Oncol,2007,25(33):5287-5312.
  • 3Baqai T,Shousha S.Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast[J].Histopathology,2003,42(5):440-447.
  • 4Paradiso A,Mangia A,Barlentta A,et al.Mammography and morphobiologic characteristics of human breast cancer[J].Tumori,1993,79(6):422-426.
  • 5Thurfjell MG,Lindgren A,Thurfjell E.Nonpalpable breast cancer:mammographic appearance as predictor of histologic type[J].Radiology,2002,222(1):165-170.
  • 6Ross JS,Fletcher JA,Linette GP,et al.The Her-2/neu gene and protein in breast cancer 2003:biomarker and target of therapy[J].Oncologist,2003,8(4):307-325.
  • 7Osborne CK,Yochmowitz MG,Knight WA 3rd,et al.The value of estrogen and progesterone receptors in the treatment of breast cancer[J].Cancer,1980,46(12 Suppl):2884-2888.
  • 8Clement A. Adebamowo,Ayotunde Famooto,Temidayo O. Ogundiran,Toyin Aniagwu,Chibuzor Nkwodimmah,Effiong E. Akang.Immunohistochemical and molecular subtypes of breast cancer in Nigeria[J].Breast Cancer Research and Treatment.2008(1)
  • 9Ihemelandu C U,,Leffall L DJr,Dewitty R L,et al.Molecular breast cancer subtypes in prem-enopausal and post menopausal African-American women:age-specific prevalence and survi-val[].Journal of Surgical Research.2007
  • 10Adebamowo C A,Famooto A,Ogundiran T O,et al.I mmunohistochemical and molecular sub-types of breast cancer in Nigeria[].Breast Cancer Research.2008

共引文献82

同被引文献132

引证文献17

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部